Professor Jennifer Rogers is Vice President, Statistical Research and Consultancy at Phastar, a leading global biometric Contract Research Organization (CRO) that provides expertise and processes to manage and deliver clinical trial planning, design, and analysis, clinical study reporting, data management, and data science services.
Jen directs research strategy at Phastar, keeping them at the forefront of statistical innovation, supervising junior team members’ research projects, mentoring the next generation of statistical leaders. Jen instituted and manages Phastar’s Expert Strategic Consulting Group, Phastar’s most influential and talented statisticians, thought leaders with a proven track record of delivering the highest level of methodological expertise and innovative services.

Jen has a PhD from the University of Warwick and a BSc and MSc from Lancaster University. She joined Phastar from the University of Oxford, where she was an Associate Professor and Director of Statistical Consultancy Services, her main research interests being clinical trial methodologies driven by applied problems with areas of expertise in survival analysis, analysis of recurrent events, and joint modelling strategies combining both. In 2013, Jen was awarded a NIHR Post-Doctoral Fellowship for “Analysis of Recurrent Events in Clinical Trials”.

A highly active member of the Royal Statistical Society, Jen just finished a term sitting on Council and a four-year stint as their VP for External Affairs. Appointed President of the British Science Association Mathematical Sciences Section in 2018, she gave a keynote speech at the British Science Festival and was the London Mathematical Society Popular Lecturer for 2018. Jen is currently a trustee for the Florence Nightingale Museum.

Stephen Corson is a Statistics Manager at Phastar, a specialist Biometrics CRO headquartered in London (UK). He started his statistical career as a lecturer and consultant statistician at a UK University where he provided statistical support and training to professionals working in business, academia and industry.

Stephen joined Phastar 5 years ago and has extensive experience in Phase 1 to Phase 3 clinical trials across multiple therapeutic areas. Stephen is passionate about improving the interactions that non-statistical colleagues have with biostatisticians and regularly gives seminars on how to interpret statistical concepts for non-statisticians.